|
|
For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.
More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.
By definition, when a medication is administered intravenously, its bioavailability is 100%.
Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.
The immune system needs 9.5 hours of sleep in total darkness to recharge completely.